# FDA recall D-841-2013

> **Sanofi US** · Class II · drug recall initiated 2013-03-07.

## Product

Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30

## Reason for recall

Subpotent drug: low fill volume in some of the capsules

## Distribution

Nationwide

## Key facts

- **Recall number:** D-841-2013
- **Recalling firm:** Sanofi US
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-07
- **Report date:** 2013-08-14
- **Termination date:** 2014-03-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bridgewater, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-841-2013

## Citation

> AI Analytics. FDA recall D-841-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-841-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*